Robbins Farley Grows Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Robbins Farley grew its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 20.0% during the first quarter, Holdings Channel reports. The institutional investor owned 5,927 shares of the company’s stock after purchasing an additional 987 shares during the quarter. Robbins Farley’s holdings in HCA Healthcare were worth $2,048,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Atwood & Palmer Inc. bought a new stake in shares of HCA Healthcare in the 1st quarter worth approximately $28,000. Whipplewood Advisors LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $31,000. Tidemark LLC purchased a new position in HCA Healthcare during the fourth quarter valued at $36,000. Legacy Investment Solutions LLC raised its stake in HCA Healthcare by 99.0% during the fourth quarter. Legacy Investment Solutions LLC now owns 191 shares of the company’s stock valued at $62,000 after buying an additional 95 shares during the last quarter. Finally, MV Capital Management Inc. raised its stake in HCA Healthcare by 31.8% during the first quarter. MV Capital Management Inc. now owns 199 shares of the company’s stock valued at $69,000 after buying an additional 48 shares during the last quarter. 62.73% of the stock is owned by institutional investors.

Insider Buying and Selling

In related news, COO Jon M. Foster sold 15,698 shares of the business’s stock in a transaction dated Tuesday, May 13th. The stock was sold at an average price of $369.32, for a total value of $5,797,585.36. Following the sale, the chief operating officer now directly owns 12,646 shares in the company, valued at approximately $4,670,420.72. The trade was a 55.38% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 1.30% of the stock is owned by company insiders.

HCA Healthcare Stock Performance

NYSE:HCA opened at $370.76 on Friday. The stock has a 50-day simple moving average of $358.43 and a two-hundred day simple moving average of $333.12. HCA Healthcare, Inc. has a 52-week low of $289.98 and a 52-week high of $417.14. The company has a debt-to-equity ratio of 69.07, a quick ratio of 0.97 and a current ratio of 1.08. The firm has a market capitalization of $89.20 billion, a PE ratio of 16.88, a P/E/G ratio of 1.10 and a beta of 1.49.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, April 25th. The company reported $6.45 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.75 by $0.70. The business had revenue of $18.32 billion during the quarter, compared to analyst estimates of $18.26 billion. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. HCA Healthcare’s revenue for the quarter was up 5.7% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.36 earnings per share. Analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current year.

HCA Healthcare Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, June 30th. Investors of record on Monday, June 16th will be given a $0.72 dividend. The ex-dividend date is Monday, June 16th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.78%. HCA Healthcare’s dividend payout ratio is currently 12.81%.

Analyst Upgrades and Downgrades

HCA has been the subject of a number of recent research reports. Royal Bank of Canada lowered their price objective on HCA Healthcare from $384.00 to $376.00 and set an “outperform” rating for the company in a research note on Monday, April 28th. Wells Fargo & Company upgraded HCA Healthcare from an “underweight” rating to an “equal weight” rating and boosted their price target for the stock from $320.00 to $385.00 in a research note on Thursday, May 29th. Barclays set a $416.00 price target on HCA Healthcare and gave the stock an “overweight” rating in a research note on Monday, June 2nd. Morgan Stanley set a $410.00 price target on HCA Healthcare and gave the stock an “equal weight” rating in a research note on Monday, June 9th. Finally, Wall Street Zen upgraded HCA Healthcare from a “hold” rating to a “buy” rating in a research report on Monday, April 28th. Seven analysts have rated the stock with a hold rating, twelve have given a buy rating and two have given a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $392.47.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.